There is no single comprehensive source for pediatric ECMO drug dosing, as evidence is limited and varies by drug, age, and circuit type.
The best approach is to combine data from key reviews (e.g., Raffaeli et al., Front Pediatr, 2019; Cheng et al., J Thorac Dis, 2018), institutional ECMO dosing guidelines (such as Northwestern Medicine’s), and neonatal formularies like NeoFax or Lexicomp, alongside therapeutic drug monitoring (TDM) whenever possible.
Hossam Elgnainy Selected answer as best
Loading

